ADMA Biologics ADMA Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's accounts payable?
- ADMA Biologics (ADMA) reported accounts payable of -$1.23M in Q1 2026.
- How has ADMA Biologics's accounts payable changed year-over-year?
- ADMA Biologics's accounts payable decreased by 968.3% year-over-year, from $142K to -$1.23M.
- What does accounts payable mean?
- Represents the net change in obligations to pay suppliers for goods and services received. An increase generally indicates that the company is utilizing trade credit to preserve cash, while a decrease suggests faster settlement of liabilities.